Data / Form D filings / OCARO PHARMACEUTICALS INC.
OCARO PHARMACEUTICALS INC.: Form D filings
OCARO PHARMACEUTICALS INC., a pharmaceuticals company in Greensboro, NC, filed 2 Form D notices with the SEC between 2009 and 2022. The latest, on November 15, 2022, reports $610,000 sold of a $610,000 offering to 12 investors.
Find out what OCARO PHARMACEUTICALS INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 204 MUIRS CHAPEL ROAD, SUITE 202, Greensboro, NC, 27410
- Phone
- (336) 544-0320
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1165139
The full lists. Form D filings in North Carolina: 984 rows, $49.20, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 15, 2022 | New notice | $610,000 | $610,000 | $0 | 12 | Nov 1, 2022 | sec.gov |
| Apr 1, 2009 | New notice | $5,175,744 | $5,175,744 | $0 | 8 | Mar 17, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Roland Johnson | Executive Officer, Director | |
| Lanty Smith | Director | |
| Bill Yates | Director | |
| Eric Barnett | Executive Officer | |
| Andy Jane | Director |
Other pharmaceuticals companies in North Carolina that filed recently
- Dignify Therapeutics, LLC $800,000 · Sep 25, 2026
Every Form D from the week of Nov 14, 2022 · All recent filings in North Carolina · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what OCARO PHARMACEUTICALS INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.